GFAP and Alzheimer disease: A post-mortem study showed that patients with AD compared to controls exhibited a significant decrease in vasopressin and NT and a corresponding increase in the Glial Fibrillary Acidic Protein (GFAP)-stained astrocyte to Nissl-stained neuron ratio in the SCN [60].